Fresenius Kidney Care Bakersfield Northeast ( Site 0647) — Bakersfield, California

Fresenius Kidney Care Bakersfield Northeast ( Site 0647) is a clinical research site located in Bakersfield, California, United States 93306.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Fresenius Kidney Care Bakersfield Northeast ( Site 0647) has participated in 1 clinical trials.

Therapeutic areas: End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bakersfield

Browse all research sites in California · View every site in Bakersfield

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fresenius Kidney Care Bakersfield Northeast ( Site 0647)?

Fresenius Kidney Care Bakersfield Northeast ( Site 0647) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fresenius Kidney Care Bakersfield Northeast ( Site 0647) conducted?

Fresenius Kidney Care Bakersfield Northeast ( Site 0647) has 1 clinical trials on record. Their work covers End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Is Fresenius Kidney Care Bakersfield Northeast ( Site 0647) accredited by Crixeo Clinical Trials?

Fresenius Kidney Care Bakersfield Northeast ( Site 0647) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fresenius Kidney Care Bakersfield Northeast ( Site 0647)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.